688265 南模生物
按盤價 
44.780 +4.010 (+9.836%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 0.530 | 1.853 | 0.380 | -1.175 | -0.304 |
| 總資產報酬率 ROA (%) | 0.456 | 1.607 | 0.331 | -1.016 | -0.269 |
| 投入資產回報率 ROIC (%) | 0.485 | 1.689 | 0.344 | -1.056 | -0.280 | 邊際利潤分析 |
| 銷售毛利率 (%) | 54.512 | 51.689 | 45.639 | 42.378 | 41.744 |
| 營業利潤率 (%) | 3.404 | 7.123 | 0.731 | -8.130 | -5.404 |
| 息稅前利潤/營業總收入 (%) | 4.684 | 7.397 | 1.001 | -7.195 | -5.618 |
| 淨利潤/營業總收入 (%) | 3.905 | 7.467 | 1.704 | -5.615 | -1.782 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 35.853 | 50.351 | -643.137 | 132.267 | 226.040 |
| 價值變動淨收益/利潤總額(%) | 105.594 | 66.862 | 745.553 | -60.227 | -123.878 |
| 營業外收支淨額/利潤總額(%) | -0.737 | -3.048 | -2.175 | 0.342 | -11.260 | 償債能力分析 |
| 流動比率 (X) | 5.041 | 5.469 | 6.555 | 6.479 | 7.471 |
| 速動比率 (X) | 4.889 | 5.383 | 6.483 | 6.391 | 7.369 |
| 資產負債率 (%) | 13.938 | 13.831 | 12.769 | 13.064 | 14.012 |
| 帶息債務/全部投入資本 (%) | 5.365 | 5.433 | 5.349 | 5.458 | 5.177 |
| 股東權益/帶息債務 (%) | 1,707.861 | 1,683.069 | 1,697.567 | 1,654.962 | 1,726.534 |
| 股東權益/負債合計 (%) | 617.444 | 623.030 | 683.158 | 665.472 | 613.699 |
| 利息保障倍數 (X) | 3.590 | 15.239 | 3.506 | -7.474 | 7.381 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 107.431 | 95.979 | 103.945 | 98.544 | 87.968 |
| 存貨周轉天數 (天) | 44.636 | 27.775 | 24.751 | 28.064 | 32.751 |
| 備註： | 即時報價更新時間為 18/09/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
